Tapewire

Nasdaq · USD

XBIT

XBiotech Inc.

Export transactions ↓
Tapewire entity
7044
SEC CIK
0001626878
Parsed reports
138

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2025 Filed Nov 12, 2025 09:51 UTC GrantDirector Stock Option · Derivative 56,000 $0.00 Strike: $2.64 $0.00
Disclosure

SEC source: 0001193125-25-276325 · ownership.xml · derivative · entry 1

Troy Tevi David · CIK 0002087820 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,000

Underlying: Common Stock · 56,000 shares

Expires 2035-10-01

Read SEC document
October 01, 2025 Filed Nov 12, 2025 09:56 UTC GrantDirector Stock Option · Derivative 92,104 $0.00 Strike: $2.64 $0.00
Disclosure

SEC source: 0001193125-25-276344 · ownership.xml · derivative · entry 1

Rademaker Craig Evan · CIK 0002086055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,104

Underlying: Common Stock · 92,104 shares

Expires 2035-10-01

Read SEC document
October 01, 2025 Filed Nov 12, 2025 14:54 UTC GrantDirector Stock Option · Derivative 51,000 $0.00 Strike: $2.64 $0.00
Disclosure

SEC source: 0001193125-25-276340 · ownership.xml · derivative · entry 1

Soffer David Spencer · CIK 0002089248 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,000

Underlying: Common Stock · 51,000 shares

Expires 2035-10-01

Read SEC document
October 01, 2025 Filed Nov 12, 2025 14:53 UTC GrantDirector Stock Option · Derivative 79,115 $0.00 Strike: $2.64 $0.00
Disclosure

SEC source: 0001193125-25-276336 · ownership.xml · derivative · entry 1

Kuendig Thomas Martin · CIK 0002088590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,115

Underlying: Common Stock · 79,115 shares

Expires 2035-10-01

Read SEC document
March 17, 2025 Filed Mar 19, 2025 15:03 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
GrantStock Option · Derivative 1,026,228 $0.00 Strike: $3.52 $0.00
Disclosure

SEC source: 0000950170-25-041946 · ownership.xml · derivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,896,609

Underlying: Common Stock · 1,026,228 shares

Expires 2035-03-16

F1 · security: On March 17, 2025 (the Grant Date) John Simard was granted nonstatutory stock options under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock at an exercise price equal to the closing price of the Company's common stock, as reported by the Nasdaq Stock Market, on the Grant Date. The options vested immediately on the Grant Date.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 16:53 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
OtherConvertible Loan Agreement · Derivative 2,470,355 $10,000,000.00 Strike: $4.05 $24,703,550,000,000.00
Disclosure

SEC source: 0000950170-25-013647 · ownership.xml · derivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 870,381

Underlying: Common Shares or Preferred Shares · 2,470,335 shares

Expires 2029-01-03

F1 · shares: On January 31, 2025, the Convertible Loan Agreement (the "Loan") dated as of January 3, 2024 between XBiotech Inc. and John Simard, the Company's Founder, President, Chief Executive Officer, and Chairman, was terminated upon full repayment of the Loan by the Company. As a result, all conversion rights to XBiotech stock associated with the Loan were extinguished.

Read SEC document
June 20, 2024 Filed Jun 21, 2024 14:15 UTC GrantDirector Stock Option · Derivative 37,500 $0.00 Strike: $5.12 $0.00
Disclosure

SEC source: 0000950170-24-076081 · ownership.xml · derivative · entry 1

MacAdam Donald H. · CIK 0001735261 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2034-06-20

Read SEC document
June 20, 2024 Filed Jun 21, 2024 14:16 UTC
MCKENZIE W THORPEDirector · 10% owner
GrantDirector Stock Option · Derivative 37,500 $0.00 Strike: $5.12 $0.00
Disclosure

SEC source: 0000950170-24-076084 · ownership.xml · derivative · entry 1

MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2034-06-20

Read SEC document
June 20, 2024 Filed Jun 21, 2024 18:16 UTC GrantDirector Stock Option · Derivative 37,500 $0.00 Strike: $5.12 $0.00
Disclosure

SEC source: 0000950170-24-076082 · ownership.xml · derivative · entry 1

Waldin Jan-Paul · CIK 0001733176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2034-06-20

Read SEC document
June 20, 2024 Filed Jun 21, 2024 18:15 UTC
Libby PeterDirector
GrantDirector Stock Option · Derivative 37,500 $0.00 Strike: $5.12 $0.00
Disclosure

SEC source: 0000950170-24-076080 · ownership.xml · derivative · entry 1

Libby Peter · CIK 0001784088 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires 2034-06-20

Read SEC document
January 03, 2024 Filed Jan 5, 2024 10:48 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
PurchaseConvertible Loan Agreement · Derivative 2,470,355 $10,000,000.00 Strike: $4.05 $24,703,550,000,000.00
Disclosure

SEC source: 0000950170-24-002316 · ownership.xml · derivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,840,736

Underlying: Common Shares or Preferred Shares · 2,470,355 shares

Expires 2029-01-03

F1 · shares: On January 3, 2024, XBiotech Inc. ("XBiotech" or the "Company") entered into a Convertible Loan Agreement (the "Loan") with John Simard, the Company's Founder, President, Chief Executive Officer and Chairman. The Loan provides $10 million in immediate funding for the construction of a new, state-of-the-art research and development facility at 5217 Winnebago Lane in Austin, Texas. The Loan is secured by the real estate and cash holdings of the Company, with interest to accrue at a simple rate equal to eight percent per year and interest-only payments to be made at six - month intervals after the Loan is funded. At Mr. Simard's election, the balance may be converted to XBiotech stock at any time the Loan balance is outstanding at a fixed conversion price equal to the average Nasdaq Official Closing Price of the common stock (as reflected on Nasdaq.com) for the five trading days immediately preceding the signing of this Agreement, which is $4.048 per share. Continued in Remarks.

F2 · derivative.underlying_shares: As of the filing date of this Form 4, Mr. Simard could obtain up to 2,470,355 XBiotech common or preferred shares by converting the full $10,000,000 Loan balance at the conversion price of $4.048 per share. The total number of shares exercisable under the Loan could fluctuate based on Mr. Simard' cumulative stock ownership and the total number of XBiotech shares outstanding.

F3 · balance_after: This figure is derived by adding the 2,470,355 shares that Mr. Simard could obtain by converting the Loan balance as of the filing date of this Form 4 to the 1,370,381 stock options Mr. Simard holds as previously disclosed in XBiotech's April 28, 2023 Schedule 14A. As stated in footnote 2 above, the total number of shares exercisable under the Loan could fluctuate based on Mr. Simard' cumulative stock ownership and the total number of XBiotech shares outstanding.

Read SEC document
June 23, 2023 Filed Jun 26, 2023 08:43 UTC GrantDirector Stock Option · Derivative 25,000 $0.00 Strike: $6.04 $0.00
Disclosure

SEC source: 0001209191-23-039576 · doc4.xml · derivative · entry 1

MacAdam Donald H. · CIK 0001735261 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-23

Read SEC document
June 23, 2023 Filed Jun 26, 2023 08:40 UTC
MCKENZIE W THORPEDirector · 10% owner
GrantDirector Stock Option · Derivative 25,000 $0.00 Strike: $6.04 $0.00
Disclosure

SEC source: 0001209191-23-039570 · doc4.xml · derivative · entry 1

MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-23

Read SEC document
June 23, 2023 Filed Jun 26, 2023 12:47 UTC GrantDirector Stock Option · Derivative 25,000 $0.00 Strike: $6.04 $0.00
Disclosure

SEC source: 0001209191-23-039579 · doc4.xml · derivative · entry 1

Waldin Jan-Paul · CIK 0001733176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-23

Read SEC document
June 23, 2023 Filed Jun 26, 2023 12:45 UTC
Libby PeterDirector
GrantDirector Stock Option · Derivative 25,000 $0.00 Strike: $6.04 $0.00
Disclosure

SEC source: 0001209191-23-039578 · doc4.xml · derivative · entry 1

Libby Peter · CIK 0001784088 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-06-23

Read SEC document
February 10, 2023 Filed Feb 17, 2023 20:00 UTC
SHIVASWAMY SUSHMAChief Scientific Officer
GrantEmployee Stock Option (right to buy) · Derivative 100,000 $0.00 Strike: $3.84 $0.00
Disclosure

SEC source: 0001209191-23-010932 · doc4.xml · derivative · entry 1

SHIVASWAMY SUSHMA · CIK 0001638762 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-02-09

F1 · derivative.exercise_date: On February 10, 2023 (the Grant Date) the reporting person was granted stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in four equal portions in two years commencing as of August 10, 2023, with an expiry of ten years from the Grant Date.

Read SEC document
June 22, 2022 Filed Jun 27, 2022 18:02 UTC GrantStock Option · Derivative 25,000 $0.00 Strike: $5.89 $0.00
Disclosure

SEC source: 0001209191-22-039518 · doc4.xml · derivative · entry 1

MacAdam Donald H. · CIK 0001735261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-22

Read SEC document
June 22, 2022 Filed Jun 27, 2022 18:00 UTC
MCKENZIE W THORPEDirector · 10% owner
GrantStock Option · Derivative 25,000 $0.00 Strike: $5.89 $0.00
Disclosure

SEC source: 0001209191-22-039516 · doc4.xml · derivative · entry 1

MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-22

Read SEC document
June 22, 2022 Filed Jun 27, 2022 21:57 UTC GrantStock Option · Derivative 25,000 $0.00 Strike: $5.89 $0.00
Disclosure

SEC source: 0001209191-22-039513 · doc4.xml · derivative · entry 1

Waldin Jan-Paul · CIK 0001733176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-22

Read SEC document
June 22, 2022 Filed Jun 27, 2022 21:54 UTC
Libby PeterDirector
GrantDirector Stock option · Derivative 25,000 $0.00 Strike: $5.89 $0.00
Disclosure

SEC source: 0001209191-22-039512 · doc4.xml · derivative · entry 1

Libby Peter · CIK 0001784088 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-22

Read SEC document
December 16, 2021 Filed Jan 13, 2022 12:18 UTC
MCKENZIE W THORPEDirector · 10% owner
Exercise / conversionStock Option · Derivative 250,000 $0.00 Strike: $10.00 $0.00
Disclosure

SEC source: 0001209191-22-003158 · doc4.xml · derivative · entry 3

MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,000

Underlying: Common Stock · 250,000 shares

Expires 2021-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2021 Filed Jan 13, 2022 12:18 UTC
MCKENZIE W THORPEDirector · 10% owner
Tax withholdingCommon Stock 213,493 $11.71 $2,500,003.03
Disclosure

SEC source: 0001209191-22-003158 · doc4.xml · nonDerivative · entry 2

MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,597,471

F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 36,507 shares of common stock on net exercise of option to purchase 250,000 shares of common stock. The Company withheld 213,493 shares of common stock underlying the option for payment of the exercise price using the closing stock price on December 16, 2021 of $11.71, pursuant to the terms of the 2005 Equity Incentive Plan.

Read SEC document
December 16, 2021 Filed Jan 13, 2022 12:18 UTC
MCKENZIE W THORPEDirector · 10% owner
Exercise / conversionCommon Stock 250,000 $10.00 $2,500,000.00
Disclosure

SEC source: 0001209191-22-003158 · doc4.xml · nonDerivative · entry 1

MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,810,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 19, 2021 Filed Nov 23, 2021 16:10 UTC
HAN QUEENAVP Finance & HR
GrantStock Option · Derivative 35,000 $0.00 Strike: $12.67 $0.00
Disclosure

SEC source: 0001209191-21-066401 · doc4.xml · derivative · entry 1

HAN QUEENA · CIK 0001638986 · VP Finance & HR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2031-11-19

Read SEC document
November 19, 2021 Filed Nov 23, 2021 16:13 UTC
SHIVASWAMY SUSHMAChief Scientific Officer
GrantStock Option · Derivative 100,000 $0.00 Strike: $12.67 $0.00
Disclosure

SEC source: 0001209191-21-066404 · doc4.xml · derivative · entry 1

SHIVASWAMY SUSHMA · CIK 0001638762 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-11-19

Read SEC document
October 18, 2021 Filed Feb 15, 2022 16:05 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 33,000 $13.07 $431,253.90
Disclosure

SEC source: 0001209191-22-009745 · doc4.xml · nonDerivative · entry 2

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,823,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 15, 2021 Filed Feb 15, 2022 16:05 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 17,000 $13.32 $226,470.60
Disclosure

SEC source: 0001209191-22-009745 · doc4.xml · nonDerivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,856,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 14, 2021 Filed Oct 15, 2021 12:26 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 21,125 $12.90 $272,523.06
Disclosure

SEC source: 0001209191-21-060523 · doc4.xml · nonDerivative · entry 4

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,873,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 13, 2021 Filed Oct 15, 2021 12:26 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 10,875 $12.83 $139,526.25
Disclosure

SEC source: 0001209191-21-060523 · doc4.xml · nonDerivative · entry 3

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,962,452

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 12, 2021 Filed Oct 15, 2021 12:26 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 18,000 $12.77 $229,939.20
Disclosure

SEC source: 0001209191-21-060523 · doc4.xml · nonDerivative · entry 2

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,973,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 07, 2021 Filed Oct 15, 2021 12:26 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 39,286 $12.45 $489,110.70
Disclosure

SEC source: 0001209191-21-060523 · doc4.xml · nonDerivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,923,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 06, 2021 Filed Oct 6, 2021 17:48 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 10,714 $12.53 $134,259.28
Disclosure

SEC source: 0001209191-21-059849 · doc4.xml · nonDerivative · entry 3

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,962,452

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 05, 2021 Filed Oct 6, 2021 17:48 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 14,218 $12.66 $180,058.17
Disclosure

SEC source: 0001209191-21-059849 · doc4.xml · nonDerivative · entry 2

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,973,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 04, 2021 Filed Oct 6, 2021 17:48 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 23,681 $13.08 $309,863.52
Disclosure

SEC source: 0001209191-21-059849 · doc4.xml · nonDerivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,987,384

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
October 01, 2021 Filed Oct 1, 2021 16:39 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 19,684 $13.23 $260,488.21
Disclosure

SEC source: 0001209191-21-058475 · doc4.xml · nonDerivative · entry 4

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,011,065

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 30, 2021 Filed Oct 1, 2021 16:39 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 18,558 $13.07 $242,463.98
Disclosure

SEC source: 0001209191-21-058475 · doc4.xml · nonDerivative · entry 3

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,030,749

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 29, 2021 Filed Oct 1, 2021 16:39 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 16,396 $13.41 $219,801.50
Disclosure

SEC source: 0001209191-21-058475 · doc4.xml · nonDerivative · entry 2

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,049,307

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 28, 2021 Filed Oct 1, 2021 16:39 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 6,263 $14.27 $89,363.62
Disclosure

SEC source: 0001209191-21-058475 · doc4.xml · nonDerivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,065,703

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 27, 2021 Filed Sep 28, 2021 10:59 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 29,890 $14.81 $442,790.46
Disclosure

SEC source: 0001209191-21-057877 · doc4.xml · nonDerivative · entry 3

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,071,966

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 24, 2021 Filed Sep 28, 2021 10:59 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 11,418 $14.49 $165,409.14
Disclosure

SEC source: 0001209191-21-057877 · doc4.xml · nonDerivative · entry 2

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,101,856

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 23, 2021 Filed Sep 28, 2021 10:59 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 9,892 $14.68 $145,219.51
Disclosure

SEC source: 0001209191-21-057877 · doc4.xml · nonDerivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,113,274

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 22, 2021 Filed Sep 22, 2021 18:12 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 19,669 $15.14 $297,757.19
Disclosure

SEC source: 0001209191-21-057295 · doc4.xml · nonDerivative · entry 3

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,123,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 21, 2021 Filed Sep 22, 2021 18:12 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 16,860 $15.24 $256,912.68
Disclosure

SEC source: 0001209191-21-057295 · doc4.xml · nonDerivative · entry 2

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,142,835

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 18:12 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 13,471 $15.06 $202,913.67
Disclosure

SEC source: 0001209191-21-057295 · doc4.xml · nonDerivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,159,695

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 14, 2021 Filed Jul 19, 2021 14:27 UTC
SIMARD JOHNDirector · Chief Executive Officer · 10% owner
SaleCommon Stock 50,000 $18.15 $907,350.00
Disclosure

SEC source: 0001209191-21-047105 · doc4.xml · nonDerivative · entry 1

SIMARD JOHN · CIK 0001639078 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,173,166

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
July 09, 2021 Filed Jul 12, 2021 11:10 UTC Exercise / conversionStock options · Derivative 10,000 $0.00 Strike: $4.40 $0.00
Disclosure

SEC source: 0001209191-21-046265 · doc4.xml · derivative · entry 2

MacAdam Donald H. · CIK 0001735261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stocks · 10,000 shares

Expires 2028-06-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2021 Filed Jul 12, 2021 11:10 UTC Exercise / conversionCommon Shares 10,000 $4.40 $44,000.00
Disclosure

SEC source: 0001209191-21-046265 · doc4.xml · nonDerivative · entry 1

MacAdam Donald H. · CIK 0001735261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2021 Filed Jul 12, 2021 15:48 UTC
Libby PeterDirector
Exercise / conversionStock options · Derivative 25,000 $0.00 Strike: $7.76 $0.00
Disclosure

SEC source: 0001209191-21-046266 · doc4.xml · derivative · entry 2

Libby Peter · CIK 0001784088 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stocks · 25,000 shares

Expires 2029-07-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 09, 2021 Filed Jul 12, 2021 15:48 UTC
Libby PeterDirector
Exercise / conversionCommon Shares 25,000 $7.76 $194,000.00
Disclosure

SEC source: 0001209191-21-046266 · doc4.xml · nonDerivative · entry 1

Libby Peter · CIK 0001784088 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 22, 2021 Filed Jun 24, 2021 10:42 UTC GrantStock Option · Derivative 25,000 $0.00 Strike: $16.21 $0.00
Disclosure

SEC source: 0001209191-21-042910 · doc4.xml · derivative · entry 1

MacAdam Donald H. · CIK 0001735261 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-06-22

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.